World’s First Transcatheter Mitral Valve Approved in Europe

• The Abbott Tendyne Transcatheter Mitral Valve Implantation (TMVI)system received the European CE mark. It is the first transcatheter mitral valve replacement (TMVR) technology in the world.

Aim:

• The main aim is to make critical need to eliminate mitral regurgitation when surgery or mitral repair is not an option in high-risk surgical patients.

Abbott:

Abbott is developing a transcatheter mitral valve to open-heart surgery. Building upon its success with the MitraClip device and many years of mitral valve experience and clinical evidence.